Levodopa Completed Phase 4 Trials for Parkinson's Disease With End of Dose "Wearing Off" / Parkinson's Disease With End of Dose Wearing Off Treatment

IndicationsStatusPurposePhase
CompletedTreatment4
clinicaltrials.gov IdentifierTitleDrugs
NCT00219284Effects of Carbidopa/Levodopa/Entacapone on Motor Function and Quality of Life in Patients With Parkinson's Disease